Increased expression of IL-18 in cutaneous graft-versus-host disease

Immunology Letters

Volumn 95, Issue 1, 2004, Pages 57-61

  Park, Hyun Jeong ^a   Kim, Ji Eun ^a   Lee, Jun Yong ^a   Cho, Baik Kee ^a   Lee, Wang Jae ^b   Kim, Taesng ^c   Yoon, Doyoung ^d   Cho, Daeho ^e  

^a The Catholic University of Korea   (South Korea)

^b Seoul National University   (South Korea)

^c Chonnam National University   (South Korea)

^d Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^e Sookmyung Women's University   (South Korea)

Author keywords

Acute GVHD; Chronic GVHD; IL 18

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 18;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE MARKER; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; SCLEROSIS; SKIN GRAFT; TERATOMA;

CHRONIC DISEASE; GRAFT VS HOST DISEASE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-18; SKIN; UP-REGULATION;

EID: 4344573548     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2004.06.011     Document Type: Article

References (19)

1. S.M. Naik, G. Cannon, G.J. Burbach, S.R. Singh, R.A. Swerlick, J.N. Wilcox, J.C. Ansel, and S.W. Caughman Human keratinocytes constitutively express interleukin-18 and secrete biologically active interleukin-18 after treatment with pro-inflammatory mediators and dinitrochlorobenzene J. Invest. Dermatol. 113 1999 766 772
2. K. Nakanishi, T. Yoshimoto, H. Tsutsui, and H. Okamura Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu Cytokine Growth Factor Rev. 12 2001 53 72
3. D. Cho, H. Song, Y.M. Kim, D. Houh, D.Y. Hur, H. Park, D. Yoon, K.H. Pyun, W.J. Lee, M. Kurimoto, Y.B. Kim, Y.S. Kim, and I. Choi Endogenous interleukin-18 modulates immune escape of murine melanoma cells by regulating the expression of Fas ligand and reactive oxygen intermediates Cancer Res. 60 2000 2703 2709
4. D. Cho, T.G. Kim, W. Lee, Y.I. Hwang, H.I. Cho, H. Han, O. Kwon, D. Kim, H. Park, and D. Houh Interleukin-18 and the costimulatory molecule B7-1 have a synergistic anti-tumor effect on murine melanoma; implication of combined immunotherapy for poorly immunogenic malignancy J. Invest. Dermatol. 114 2000 928 934
5. H.J. Park, D.G. Byun, T.S. Kim, Y.I. Kim, J.S. Kang, E.S. Hahm, S.H. Kim, W.J. Lee, H.K. Song, D.Y. Yoon, C.J. Kang, C. Lee, D. Houh, H. Kim, B. Cho, Y. Kim, Y.H. Yang, K.H. Min, and D.H. Cho Enhanced IL-18 expression in common skin tumors Immunol. Lett. 79 2001 215 219
6. D. Elder R. Elenitsas C. Jaworsky B. Johnson Jr. Lever's histopathology of the skin 1997 Lippincott-Raven Philadelphia 701 720
7. H. Goker, I.C. Haznedaroglu, and N.J. Chao Acute graft-vs.-host disease: pathobiology and management Exp. Hematol. 29 2001 259 277
8. Y. Fujimori, H. Takatsuka, Y. Takemoto, H. Hara, H. Okamura, K. Nakanishi, and E. Kakishita Elevated interleukin (IL)-18 levels during acute graft-versus-host disease after allogeneic bone marrow transplantation Br. J. Haematol. 109 2000 652 657
9. V. Ratanatharathorn, L. Ayash, H.M. Lazarus, J. Fu, and J.P. Uberti Chronic graft-versus-host disease: clinical manifestation and therapy Bone Marrow Transplant. 28 2001 121 129
10. I. Okamoto, K. Kohno, T. Tanimoto, K. Iwaki, T. Ishihara, S. Akamatsu, S. Ikegami, and Ml. Kurimoto IL-18 prevents the development of chronic graft-versus-host disease in mice J. Immunol. 164 2000 6067 6074
11. Y.S. Cho, J.W. Kang, M. Cho, C.W. Cho, S. Lee, Y.K. Choe, Y. Kim, I. Choi, S.N. Park, S. Kim, C.A. Dinarello, and D.Y. Yoon Down modulation of IL-18 expression by human papillomavirus type 16 E6 oncogene via binding to IL-18 FEBS Lett. 501 2001 139 145
12. S.H. Kim, T. Azam, D.Y. Yoon, L.L. Reznikov, D. Novick, M. Rubinstein, and C.A. Dinarello Site-specific mutations in the mature form of human IL-18 with enhanced biological activity and decreased neutralization by IL-18 binding protein Proc. Natl. Acad. Sci. USA 98 2001 3304 3309
13. K.G. Lerner, G.F. Kao, R. Storb, C.D. Buckner, R.A. Clift, and E.D. Thomas Histopathology of graft-versus-host reaction (GVHR) in human recipients of marrow from HLA-matched sibling donors Transplant. Proc. 6 1974 367 371
14. H. Yamada, J. Chihara, K. Hamada, M. Matsukura, T. Yudate, K. Maeda, K. Tubaki, and T. Tezuka Immunohistology of skin and oral biopsies in graft-versus-host disease after bone marrow transplantation and cytokine therapy J. Allergy Clin. Immunol. 100 1997 S73 S76
15. P. Reddy, T. Teshima, M. Kukuruga, U. Duffner, Y. Maeda, K.R. Cooke, and J.L. Ferrara Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis J. Exp. Med. 194 2001 1433 1440
16. H. Itoi, Y. Fujimori, H. Tsutsui, K. Matsui, S. Futatsugi, H. Okamura, H. Hara, T. Hada, E. Kakishita, and K. Nakanishi Fas ligand-induced caspase-1-dependent accumulation of interleukin-18 in mice with acute graft-versus-host disease Blood 98 2001 235 237
17. H.Z. Hu, G.L. Li, Y.K. Lim, S.H. Chan, and E.H. Yap Kinetics of interferon-gamma secretion and its regulatory factors in the early phase of acute graft-versus-host disease Immunology 98 1999 379 385
18. H. Nakamura, K. Komatsu, M. Ayaki, S. Kawamoto, M. Murakami, N. Uoshima, T. Yagi, T. Hasegawa, M. Yasumi, T. Karasuno, H. Teshima, A. Hiraoka, and T. Masaoka Serum levels of soluble IL-2 receptor, IL-12, IL-18, and IFN-gamma in patients with acute graft-versus-host disease after allogeneic bone marrow transplantation J. Allergy Clin. Immunol. 106 2000 S45 S50
19. D. Arnold, C. Wasem, P. Juillard, P. Graber, I. Cima, C. Frutschi, S. Herren, S. Jakob, S. Alouani, C. Mueller, and Y. Chvatchko IL-18-independent cytotoxic T lymphocyte activation and IFN-gamma production during experimental acute graft-versus-host disease Int. Immunol. 14 2002 503 511